Cerenome is trading 7.01% up now at $2.90, with no company-specific announcement identified for September 2, 2026.

  • CNBC reports no recent news for the security.
  • The latest reported quarterly update showed a revenue miss and wider-than-expected loss, but predates today’s move.
  • The broader market is slightly weaker, so global sentiment does not clearly explain the upward move.